A Zepbound cost calculator helps patients estimate their monthly out-of-pocket expenses for tirzepatide injections by factoring in insurance coverage, pharmacy type, dosage tier, and available savings programs. In 2026, Zepbound list prices range from approximately $1,060 to $1,350 per month depending on dose, but most insured patients pay far less.
What Is Zepbound and Why Does Cost Vary So Dramatically in 2026?
Zepbound (tirzepatide) is an FDA-approved injectable medication manufactured by Eli Lilly and Company, cleared for chronic weight management in adults with obesity or overweight with at least one weight-related condition. According to FDA.gov, tirzepatide works as a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, making it one of the most mechanistically advanced weight loss medications currently available on the market.
The reason cost varies so dramatically from one patient to another comes down to several interconnected factors. Insurance formulary placement, prior authorization requirements, your specific plan's tier structure, the pharmacy you use, your geographic location, and whether you qualify for manufacturer savings programs all play a role. A patient with generous employer-sponsored insurance might pay as little as $25 per month through a copay card, while someone without coverage could face the full list price exceeding $1,300. Understanding these variables is precisely why using a dedicated calculator matters so much.
How Our Zepbound Cost Calculator Works: Methodology and Data Sources
At GLP-1 Cost Calculator, transparency in methodology is a core commitment. Our Zepbound cost calculator draws on several verified data streams to generate personalized estimates that are as accurate and current as possible.
Pricing Data Sources
Our baseline pricing data is sourced from Eli Lilly's published Wholesale Acquisition Cost (WAC) figures, which represent the list price before any discounts or rebates. We cross-reference these figures quarterly against pricing databases maintained by pharmacy benefit managers and publicly available drug pricing tools. For 2026, the WAC figures by dose tier are as follows: the 2.5 mg starting dose is approximately $1,060 per four-week supply, the 5 mg dose runs approximately $1,100, the 7.5 mg and 10 mg doses approach $1,200 to $1,250, and the 12.5 mg and 15 mg doses reach $1,300 to $1,350 per month. These are list prices only and do not reflect what most patients actually pay.
Insurance Coverage Determinations
Coverage determinations in our calculator are based on aggregated formulary data from major commercial insurance carriers, Medicare Part D plan data from the Centers for Medicare and Medicaid Services (CMS), and Medicaid state plan information where available. It is important to understand that Zepbound coverage for obesity specifically — as opposed to type 2 diabetes — remains uneven across plans. Medicare, under traditional fee-for-service, has historically excluded obesity-only medications, though plan-level coverage continues to evolve. Our calculator flags these nuances so you can identify whether you need to verify coverage with your specific insurer.
Savings Program Integration
Eli Lilly's Zepbound Savings Card program is incorporated into our estimates for eligible commercially insured patients. As of mid-2026, eligible patients may pay as little as $25 for a one-month supply or $50 for a three-month supply through this program, subject to income and insurance eligibility requirements. Our calculator applies this logic automatically when you indicate you have commercial insurance and are not enrolled in a federal or state government health program.
You can access our interactive tool directly at glp1costcalculator.com/calculator/ to run a personalized Zepbound cost estimate in under two minutes.
Breaking Down Zepbound Costs by Insurance Type in 2026
Commercial Insurance
Patients with employer-sponsored or marketplace commercial insurance have the most favorable access to Zepbound savings. When the medication is covered, typical cost-sharing after deductibles ranges from $25 to $150 per month depending on your plan's tier placement. Many commercial plans place Zepbound on Tier 3 or Tier 4, meaning you will likely need to meet your annual deductible before cost-sharing kicks in. During the deductible phase, you may pay close to full price, which is why understanding your plan's structure before starting treatment is critical financial planning.
Medicare Part D
Medicare coverage for Zepbound when prescribed solely for weight loss remains limited under traditional Medicare Part D, though the Inflation Reduction Act provisions continue to reshape the landscape. Some Medicare Advantage plans have added obesity medication coverage as a supplemental benefit. If you are on Medicare, our calculator will prompt you to verify your specific Part D or Medicare Advantage plan's formulary before generating an estimate, because blanket statements about Medicare coverage of Zepbound can be misleading and inaccurate.
Medicaid
Medicaid coverage for GLP-1 medications like Zepbound varies significantly by state. Some states have expanded their formularies to include tirzepatide for obesity management, while others restrict coverage to type 2 diabetes indications only. Our calculator includes a state-by-state Medicaid coverage flag so you can see the general coverage posture in your state, though verification with your state Medicaid office is always recommended.
No Insurance or Underinsured
For patients without insurance coverage, the options include cash-pay pharmacy pricing (which can sometimes be negotiated below WAC through pharmacy discount programs), Eli Lilly's LillyInsulinValue program or patient assistance programs for qualifying low-income patients, and compounding pharmacy alternatives where regulatory status permits. Our calculator presents all available options ranked by estimated out-of-pocket cost so you can make an informed comparison.
Zepbound vs. Other GLP-1 Medications: A Cost Context
Understanding Zepbound's cost in isolation is only half the picture. Many patients and clinicians compare Zepbound against Wegovy (semaglutide) and other GLP-1 receptor agonists. In 2026, Wegovy carries a similar list price in the $1,300 to $1,450 range per month, while older GLP-1 agents like liraglutide tend to be less expensive but also generally considered less effective for weight loss based on clinical trial data.
The clinical efficacy data matters here because cost-effectiveness is not just about price per pill or injection — it is about cost per pound lost, cost per cardiovascular event prevented, and long-term health economic outcomes. Zepbound's SURMOUNT trial program, as reviewed by the FDA, demonstrated mean body weight reductions of approximately 15 to 20 percent over 72 weeks at higher doses, which compares favorably to other agents and may justify higher premiums in formal health economic analyses.
For a side-by-side comparison of GLP-1 medication costs, visit our GLP-1 medication cost comparison page where we break down pricing across all major agents currently available in 2026.
7 Practical Strategies to Reduce Your Zepbound Costs in 2026
1. Use the Manufacturer Savings Card
Eli Lilly's Zepbound Savings Card is the single most impactful cost-reduction tool for commercially insured patients. Enrollment is straightforward through Lilly's official patient support resources, and eligible patients can dramatically reduce their monthly cost. Always verify current program terms directly with Lilly, as savings program structures can change.
2. Request a Prior Authorization Appeal if Denied
Insurance denials for Zepbound are common, particularly on the first submission. A well-documented appeal that includes clinical notes, BMI documentation, comorbidity evidence, and your prescriber's letter of medical necessity succeeds in a meaningful percentage of cases. Do not accept a first denial as final.
3. Use a Specialty or Mail-Order Pharmacy
Specialty pharmacies contracted with your insurer often have better negotiated rates for injectable biologics like Zepbound. Mail-order pharmacies frequently offer 90-day supply discounts that further reduce the effective monthly cost.
4. Compare 90-Day Versus 30-Day Supply Pricing
Many savings programs and insurance plans offer better unit pricing on 90-day supplies. Run both scenarios through our calculator to see whether a three-month prescription generates meaningful additional savings.
5. Ask About Patient Assistance Programs
For patients who do not qualify for commercial savings cards — including those on government insurance — Eli Lilly's Lilly Cares Foundation patient assistance program provides Zepbound at no cost to qualifying low-income patients. Income thresholds and eligibility criteria apply.
6. Explore HSA and FSA Payment Options
Zepbound prescribed for an FDA-approved indication is generally an eligible expense under Health Savings Accounts (HSA) and Flexible Spending Accounts (FSA). Using pre-tax dollars to cover out-of-pocket costs effectively reduces your real cost by your marginal tax rate, which can be 22 to 37 percent for many patients.
7. Re-run Your Cost Estimate Annually During Open Enrollment
Insurance formularies change every plan year. A plan that covered Zepbound at a low tier in 2025 may have repositioned it in 2026. Running a fresh estimate during open enrollment allows you to select the plan that best aligns with your medication needs and budget for the coming year.
Understanding Prior Authorization for Zepbound
Prior authorization (PA) is a process insurers use to verify medical necessity before approving coverage for high-cost medications. For Zepbound, PA criteria typically require documentation of a BMI of 30 or greater, or BMI of 27 or greater with at least one weight-related comorbidity such as hypertension, type 2 diabetes, dyslipidemia, or obstructive sleep apnea. Some plans additionally require evidence of previous weight loss attempts through lifestyle interventions or other pharmacological therapies.
Working closely with your prescribing clinician to ensure all required documentation is submitted on the first PA request significantly improves approval rates and speeds up the timeline to treatment initiation. Our calculator includes a PA documentation checklist you can share with your healthcare team to streamline this process.
What the FDA Approval Means for Cost and Access
Zepbound received FDA approval in November 2023 for chronic weight management, a regulatory milestone that has gradually increased commercial insurance coverage as payers update their formularies to reflect the medication's approved indication. According to FDA.gov, Zepbound is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial BMI of 30 kg/m² or greater, or 27 kg/m² or greater in the presence of at least one weight-related comorbid condition.
This FDA approval status is directly relevant to cost because medications with clear approved indications are more likely to receive favorable formulary placement and prior authorization approval compared to off-label uses. As a patient advocate, I always recommend that patients and their providers reference the FDA-approved label when communicating with insurance companies, because it establishes the clinical legitimacy of the prescription.
How to Use the GLP-1 Cost Calculator for Zepbound
Using our calculator is designed to take under two minutes and requires no account creation. You will be asked to enter your insurance type, your state of residence, your prescribed Zepbound dose, whether you have commercial insurance that qualifies for the Lilly Savings Card, and your pharmacy preference. The calculator then generates a personalized estimate showing your estimated monthly cost across multiple scenarios including with savings card, without savings card, mail-order, and patient assistance program pathways.
For patients who want to model multiple GLP-1 options simultaneously, our full GLP-1 calculator allows side-by-side comparisons so you and your provider can make a truly informed treatment decision that balances clinical suitability with financial feasibility.
Frequently Asked Questions About Zepbound Costs in 2026
Does Medicare cover Zepbound in 2026?
Traditional Medicare Part D generally does not cover Zepbound when prescribed solely for obesity, though some Medicare Advantage plans have added obesity medication coverage. Verify with your specific plan, as coverage is evolving and varies widely.
Is Zepbound cheaper than Wegovy?
At list price, Zepbound and Wegovy are comparably priced in 2026. Your actual out-of-pocket cost depends on your specific insurance formulary placement for each drug, making a direct comparison through our calculator the most accurate approach.
Can I use a GoodRx coupon for Zepbound?
GoodRx and similar discount programs can provide some savings on Zepbound at participating pharmacies, though the discounts are typically modest relative to the list price. For commercially insured patients, the Lilly Savings Card generally produces greater savings than third-party coupons.
How often does Zepbound pricing change?
Pharmaceutical list prices can change annually, and insurance formulary placements are updated each plan year. We update our calculator data quarterly to reflect current pricing, and we recommend verifying current figures with your pharmacy at the time of dispensing.
This content is for informational purposes only and does not constitute medical advice. GLP-1 medication costs and coverage vary by plan and individual. Consult your healthcare provider and pharmacist. Verify current information at FDA.gov.